ESCAPE: An Open-Label Trial of Personalized Immunotherapy in Critically lll COVID-19 Patients

• Main Authors: Eleni Karakike (Author), George N. Dalekos (Author), Ioannis Koutsodimitropoulos (Author), Maria Saridaki (Author), Chryssa Pourzitaki (Author), Georgios Papathanakos (Author), Antigone Kotsaki (Author), Stamatios Chalvatzis (Author), Vasiliki Dimakopoulou (Author), Nikolaos Vechlidis (Author), Elisabeth Paramythiotou (Author), Christina Avgoustou (Author), Aikaterini Ioakeimidou (Author), Elli Kouriannidi (Author), Apostolos Komnos (Author), Evangelia Neou (Author), Nikoletta Rovina (Author), Eleni Stefanatou (Author), Haralampos Milionis (Author), George Nikolaidis (Author), Antonia Koutsoukou (Author), Georgia Damoraki (Author), George Dimopoulos (Author), Vassileios Zoumpos (Author), Jesper Eugen-Olsen (Author), Karolina Akinosoglou (Author), Nikolaos K. Gatselis (Author), Vasilios Koulouras (Author), Eleni Gkeka (Author), Nikolaos Markou (Author), Mihai G. Netea (Author), Evangelos J. Giamarellos-Bourboulis (Author)
• Format: Book
• Published: Karger Publishers, 2021-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Macrophage activation-like syndrome (MALS) and complex immune dysregulation (CID) often underlie acute respiratory distress (ARDS) in COVID-19. We aimed to investigate the effect of personalized immunotherapy on clinical improvement of critical COVID-19. Methods: In this open-label prosp...